Generics Industry News Search
 |
|
|
|
|
|
|
February 2012 News Archive |
|
|
| |
|
MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market and the Jasdaq Market of the Osaka Securities Exchange, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers the use of Ibudilast for the treatment of progressive forms of multiple sclerosis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
OctoPlus announces today that a formulation development and manufacturing contract has been signed with Ferring, a leading innovative pharmaceutical company....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In response to investment community speculation following release of the transcript of a pre-trial conference call related to its Lidoderm patent challenge, Watson Pharmaceuticals, Inc. today issued the following statement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Valeant Pharmaceuticals International, Inc. today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel, a generic version of Benzaclin, and 5% fluorouracil cream, an authorized generic of Efudex, to Mylan...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Acorda Therapeutics today announced that the company has partnered with Watson Pharma, to introduce Tizanidine hydrochloride capsules, an authorised generic version of Zanaflex capsules (Tizanidine hydrochloride)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has reached a settlement with Janssen Pharmaceuticals, Inc. on outstanding patent litigation related to Watson's generic version of Janssen's Ortho Tri-cyclen Lo...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Drospirenone and Ethinyl Estradiol and Levomefolate Calcium tablets, and Levomefolate Calcium tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion Pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
GenericsWeb, the leader in established pharmaceutical patent analysis and searching, recently published an article that analyses opportunities in launching generic versions of Merck's blockbuster asthma treatment Montelukast (Singulair). Montelukast products had global sales of USD $5bn in 2010....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Merck today announced the formation of a new joint venture with Supera Farma Laboratorios, a Brazilian pharmaceutical company co-owned by Cristalia and Eurofarma...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced the launch of Donepezil in some of Europe's biggest markets, immediately after the patents expired...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par Pharmaceutical Companies, Inc. announced today that it has completed the acquisition of privately-held Edict Pharmaceuticals Private Limited, an India-based developer and manufacturer of generic pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer Inc. and Zhejiang Hisun Pharmaceutical, a leading pharmaceutical company in China, today signed a framework agreement, advancing their previously announced memorandum of understanding (MOU) to establish a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer and Mylan say they have agreed to settle their patent infringement lawsuit against the French drugmaker Sanofi over pre-filled injections designed to treat severe allergic reactions...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories, announced today that its subsidiary, Ranbaxy Australia has launched Atorvastatin 10 mg, 20 mg, 40 mg and 80 mg tablets in the Australian market, after receiving approval from the Therapeutic Goods Administration, the regulatory authority in Australia...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Supreme Court rejected Johnson & Johnson's request to reinstate the largest patent-infringement verdict in American history...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Santarus, Inc. and Depomed, Inc. today announced that they have entered into a settlement agreement with Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, Inc., to resolve pending patent litigation involving Glumetza...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The United States Patent & Trademark Office has informed BioDelivery Sciences International, Inc. that it has rejected all claims by MonoSol Rx, LLC in its US Patent No. 7,425,292 which is currently being asserted against BDSI and its commercial partners for Onsolis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
GlaxoSmithKline Plc has the right to sell an authorized copy of its Paxil CR antidepressant to Apotex Inc., a U.S. judge ruled, denying a bid by Mylan Inc. to block such sales...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. president and CEO of Americas Bill Marth told Merrill Lynch that the company "appears very confident on its legal defense for Copaxone"...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Samsung Biologics and Biogen Idec announced today that the companies have established their joint venture, Samsung Bioepis, to develop, manufacture and market biosimilars in keeping with their agreement announced in December...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
